SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 12, 1999
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission (IRS Employer
or incorporation) File Number) Identification)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
Osteotech, Inc. ("Osteotech") previously reported on a Form 8-K dated April
15, 1999, that GenSci Regeneration Sciences Inc. ("GenSci"), had made a motion
in the United States District Court for the Central District of California to
amend its patent infringement claims against Osteotech to allege that Grafton(R)
DBM Gel and Grafton(R) DBM Putty were infringing products. GenSci also amended
its complaint to add claims of contributory infringement and inducement of
infringement against Osteotech, in addition to its prior claims of direct
infringement. Lastly, GenSci's amended complaint adds to its false advertising
claims against Osteotech allegations that persons acting on Osteotech's behalf
or with its consent have made misleading statements with respect to GenSci's
products. This motion has been granted. Osteotech believes all of GenSci's
claims to be without merit and intends to vigorously defend against them, and
has filed an amended answer that is consistent with this position.
Certain information included in this report contains forward looking
statements made pursuant to the Private Securities Litigation Reform Act of
1995. Such statements are based on assumptions that Osteotech believes are
reasonable, but are subject to a wide range of risks and uncertainties and,
therefore, there can be no assurance that actual results may not differ
materially from those expressed or implied by such forward-looking statements.
Factors that could cause actual results to differ materially, include but are
not limited to, the uncertainties involved in any litigation, including
litigation involving the enforcement of patents, and other factors which are
<PAGE>
detailed from time to time in Osteotech's SEC filings, including Osteotech's
Report on Form 10-K dated December 31, 1998, incorporated herein by reference,
for a description of such factors.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 1, 1999
OSTEOTECH, INC.
(Registrant)
By: /s/ MICHAEL J. JEFFRIES
---------------------------
Michael J. Jeffries
Executive Vice President,
Chief Operating Officer and
Chief Financial Officer
And Secretary
